Finally, we noted that there is a similar comment solicitation on a payment policy for SaaS under the Physician Fee Schedule, and directed readers to the CY 2026 PFS proposed rule to provide comments
The duration and severity of headaches vary based on individual factors including prior GLP-1 exposure, baseline hydration status, and genetic predisposition to medication side effects
In Retatrutide trials, 91.7% of participants achieved at least 10% weight loss
Physiol Rev 98(4):2381-2430
Novo Nordisk, the company that makes Rybelsus, Ozempic, and Wegovy, has been studying a high-dose form of semaglutide that can be taken by mouth specifically for weight loss
This is an educational resource: consult a qualified healthcare provider before acting on any information